Trial RPCEC00000307
Publication Esquivel-Moynelo I, medRxiv, 2020
Primary outcome on the report: Time to SARS-CoV-2 RNA negativization (absence of the virus according to the RT-PCR) in positive patients after starting antiviral therapy was the virological endpoint.
The clinical evaluation considered the time to progression to severe COVID-1